NCI
NCI Awards up to $150M Under Genomic Characterization Center Contract
The contractors are Sampled, the University of Southern California, UNC Chapel Hill, the New York Genome Center, Washington University in St. Louis, and SeqMatic.
Biden Cancer Moonshot Announces New Initiatives to Improve Diagnosis, Precision Treatments
The program announced a series of new public and private initiatives and projects designed to support its stated goal of halving the cancer death rate over the next 25 years.
The NCI-led Vanguard study has selected tests from Guardant Health and ClearNote Health to move forward after a vigorous technology assessment.
BRCA2 Variants Classified in Saturation Genome Editing Studies
Research teams relied on CRISPR-Cas9-based editing and sequencing to perform high-throughput function evaluations of loss-of-function variants in exons 15 to 26 of BRCA2.
Caris Life Sciences, ECOG-ACRIN to Analyze Breast Tumor Samples From Landmark TAILORx Study
Through a new partnership, Caris will use its comprehensive genomic profiling tests to sequence more than 10,000 early-stage breast tumors collected in TAILORx.